Exploration of 1-(3-chloro-4-(4-oxo-4H-chromen-2-yl)phenyl)-3-phenylurea derivatives as selective dual inhibitors of Raf1 and JNK1 kinases for anti-tumor treatment
10.1016/j.bmc.2012.04.006
Saved in:
Main Authors: | Jin, F., Gao, D., Zhang, C., Liu, F., Chu, B., Chen, Y., Chen, Y.Z., Tan, C., Jiang, Y. |
---|---|
Other Authors: | PHARMACY |
Format: | Article |
Published: |
2014
|
Subjects: | |
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/105943 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
(1R,3R,4R,6S)-4-(7-Methoxy-2-oxo-2H-chromen-6-yl)-1-methyl-3, 6-dioxabicyclo[3.1.0]hexan-2-yl acetate
by: Phakhodee,W., et al.
Published: (2015) -
Stress-induced immediate-early gene, egr-1, involves activation of p38/JNK1
by: Lim, C.P., et al.
Published: (2014) -
The crystal structure of JNK from Drosophila melanogaster reveals an evolutionarily conserved topology with that of mammalian JNK proteins
by: Sarin Chimnaronk, et al.
Published: (2017) -
A Δraf1-ER-inducible oncogenic zebrafish liver cell model identifies hepatocellular carcinoma signatures
by: He, S., et al.
Published: (2014) -
Novel anti-apoptotic mechanism of A20 through targeting ASK1 to suppress TNF-induced JNK activation
by: Won, M., et al.
Published: (2014)